Latest / Parkinson's Disease Education Podcast

From Lab Bench to Brain: The Truth About Ivermectin and Parkinson's
In this episode (watch on YouTube) we examine recent lab and animal research suggesting ivermectin — a widely used antiparasitic — can alter striatal circuits and enhance L-DOPA responses in preclinical Parkinson's models.
We'll explain the likely mechanisms (ion-channel modulation at P2X4 and nicotinic receptors), review safety concerns (blood-brain-barrier and neurotoxicity risks), and explain why there are no human trials yet proving efficacy in Parkinson's.
Sources and further reading are here:
1. Ivermectin increases striatal cholinergic activity to facilitate dopamine terminal function…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.